Wang Quanlin, Sun Shusen, Zhang Wei, Cao Dan, Jin Yisu
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
College of Pharmacy and Health Sciences, Western New England University, Springfild, MA, USA.
Per Med. 2025 Feb;22(1):21-27. doi: 10.1080/17410541.2024.2441651. Epub 2024 Dec 14.
Pharmacogenomics (PGx), an integral part of functional genomics and molecular pharmacology, has evolved significantly over the past decade. Our study reveals that PGx education in China and the United States has made substantial progress, with a particular emphasis on integrating PGx into medical curricula and clinical practice, leading to improved therapeutic strategies and patient outcomes. Consequently, both China and the United States are dedicated to fostering advancements in PGx education. This paper reviews PGx education in these two countries, highlighting its importance and providing an in-depth look at the current status and challenges within universities and clinical settings. Furthermore, it offers recommendations for advancing PGx education and contemplates future trends in both nations.
药物基因组学（PGx）作为功能基因组学和分子药理学的一个组成部分，在过去十年中取得了显著进展。我们的研究表明，中国和美国的PGx教育取得了长足进步，特别强调将PGx纳入医学课程和临床实践，从而改善了治疗策略和患者预后。因此，中国和美国都致力于推动PGx教育的发展。本文回顾了这两个国家的PGx教育情况，强调其重要性，并深入探讨了大学和临床环境中的现状及挑战。此外，还为推进PGx教育提供了建议，并展望了两国未来的发展趋势。
